A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
A Study of LY3039478 in Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Fluorodeoxyglucose Imaging Studies to Detect Lymphoma
- Status
- WITHDRAWN
- Phase
- N/A
Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of Elderly
- Status
- WITHDRAWN
- Phase
- NA
Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal Lymphadenopathies
- Status
- COMPLETED
- Phase
- PHASE4
Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL)
- Status
- WITHDRAWN
- Phase
- PHASE2
Italian Platelet Technology Assessment Study
- Status
- TERMINATED
- Phase
- PHASE3
Lymphoma and T Helper 2 Cytokines Relationship With Prognostic Markers
- Status
- COMPLETED
- Phase
- N/A
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
- Status
- COMPLETED
- Phase
- PHASE1
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE1
A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of LY2875358 in Japanese Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Early Rehabilitation of Cancer Patients
- Status
- COMPLETED
- Phase
- NA
PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Pharmacokinetic Profile of CKD-581
- Status
- COMPLETED
- Phase
- PHASE1